Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started
RI-MUHC team studies a novel, fully automated insulin delivery system
A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Jean Bourbeau and Togas Tulandi!
RI-MUHC researchers contribute to global study of babies born with birth defects
A new study published in The Lancet finds that survival for babies born with a birth defect – otherwise known...
New Quebec study evaluates long-term complications of COVID-19
RI-MUHC researcher Thao Huynh has been awarded a grant from Pfizer to conduct the IMPACT QUEBEC COVID-19 Long Haul Study
Fever is now more often a sign of serious bacterial infection
RI-MUHC researchers advocate for extra vigilance with feverish infants as new study shows startling numbers of serious bacterial infections during...
Dr. Jonathan Afilalo wins Prize for Outstanding Emerging Researchers
Fundamentally changing how cardiologists approach older patients
Services for clinical research are going strong at the Centre for Innovative Medicine
Experts at the CIM technology platforms are on site to support clinical research
Evaluation of meningitis risk in infants drives new RI-MUHC study
Results published in JAMA Network Open may change practice for young infants with fever
Meet the winners of the Principal's Prize for Public Engagement through Media
Two members of the RI-MUHC distinguished